A PYMNTS Company

US: Generics’ motion to dismiss price fixing claims denied

By  |  April 9, 2017

Six drug companies including Mylan NV and Teva Pharmaceuticals have lost a bid to dismiss lawsuits accusing them of engaging in a scheme to fix prices for the generic blood pressure medication propranolol.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    US District Judge Jed Rakoff in Manhattan on Thursday largely denied the drug companies’ motions to dismiss the proposed class actions, tossing only certain state-law claims brought by direct purchasers of propranolol.

    Full Content: Reuters

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.